These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3904855)

  • 1. Cancer treatment with Staphylococcus aureus protein A.
    Solal-Celigny P; Simeon J; Herrera A; Boivin P
    Biomed Pharmacother; 1985; 39(4):177-86. PubMed ID: 3904855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adsorption of plasma from tumor-bearing hosts over protein A--containing nonviable Staphylococcus aureus Cowan I: possible mechanism of antitumor reactions.
    Ray PK; McLaughlin D; Allen P; Bandyopadhyay S; Idiculla A; Clarke L; Mark R; Rhoads JE; Bassett JG; Cooper DR
    J Biol Response Mod; 1984; 3(3):293-302. PubMed ID: 6379112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials with Staphylococcus aureus and protein A in the treatment of malignant disease.
    Messerschmidt GL; Bowles CA; Henry DH; Deisseroth AB
    J Biol Response Mod; 1984; 3(3):325-9. PubMed ID: 6379115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experiences with extracorporeal immunoperfusion of plasma from cancer patients.
    Korec S; Smith FP; Schein PS; Phillips TM
    J Biol Response Mod; 1984; 3(3):330-5. PubMed ID: 6379116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal protein A adsorption in neoplastic disease: analysis of physicochemical aspects.
    Murphy RM; Colton CK; Yarmush ML
    Mol Biother; 1989; 1(4):186-207. PubMed ID: 2684224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal perfusion of plasma over immobilized protein A in a patient with Kaposi's sarcoma and acquired immunodeficiency.
    Kiprov DD; Lippert R; Jones FR; Lagios MD; Balint JP; Cohen RJ
    J Biol Response Mod; 1984; 3(3):341-6. PubMed ID: 6379118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of Staphylococcus aureus Cowan I immunoperfusion.
    Messerschmidt G; Bowles C; Dean D; Parker M; Lester R; Dowling R; Holohan T; Osborne L; Schaff BF; McCormack K; Corbitt R; Phillips T; Glatstein E; Deisseroth A
    Cancer Treat Rep; 1982 Dec; 66(12):2027-31. PubMed ID: 7139644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of frequency of plasma adsorption over protein A-containing Staphylococcus aureus on regression of rat mammary adenocarcinomas: modification of antitumor immune response and tumor histopathology.
    Ray PK; Mohammed J; Allen P; Raychaudhuri S; Dohadwala M; Bandyopadhyay S; Mark R
    J Biol Response Mod; 1984; 3(1):39-59. PubMed ID: 6707699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcal protein A in neoplastic disease.
    Terman DS
    J Biol Response Mod; 1984; 3(3):316-24. PubMed ID: 6379114
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with Staphylococcus aureus and protein A in the treatment of canine malignancies.
    Bowles CA; Messerschmidt G; Deisseroth AB
    J Biol Response Mod; 1984; 3(3):260-5. PubMed ID: 6379110
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement function in mAb-mediated cancer immunotherapy.
    Gelderman KA; Tomlinson S; Ross GD; Gorter A
    Trends Immunol; 2004 Mar; 25(3):158-64. PubMed ID: 15036044
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stimulation of the immunological reactivity of cancer patients by Eleutherococcus extract].
    Kupin VI; Polevaia EB
    Vopr Onkol; 1986; 32(7):21-6. PubMed ID: 3526720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion of plasma over Staphylococcus aureus: release of bacterial products is related to regression of tumor.
    Gordon BR; Matus RE; Hurvitz AI; MacEwen EG; Saal SD; Stenzel KH; Rubin AL; Hyden H
    J Biol Response Mod; 1984; 3(3):266-70. PubMed ID: 6379111
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of Protein-A in the treatment of malignancy: rationale and the NCI experience.
    Messerschmidt GL; Bowles C; Parrillo J; Parker M; Shelhammer J; Dowling R; Osborne L; Corbitt R; McCormack K; Longo D; Deisseroth A
    Prog Clin Biol Res; 1982; 106():385-90. PubMed ID: 6757952
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultrastructural changes in breast tumors of patients following treatment with plasma perfused over immobilized protein A.
    Daskal Y; Mattioli CA; Terman DS
    J Biol Response Mod; 1984; 3(3):247-54. PubMed ID: 6379108
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro tumoricidal activity of immunoadsorbed leukemic serum.
    Miller WJ; Branda RF
    J Biol Response Mod; 1984; 3(3):231-4. PubMed ID: 6379106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor vaccination: where we stand.
    Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
    Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal modification of plasma and whole blood.
    Saal SD; Gordon BR
    Prog Clin Biol Res; 1982; 106():375-84. PubMed ID: 6757951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.